LENZ Therapeutics, Inc.LENZNASDAQ
Loading
Gross Profit Growth TrendStable
Percentile Rank100
5Y CAGR+8.1%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

5Y CAGR
+8.1%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
1.5x
Solid growth
Streak
1 qtr
Consecutive growthStable
PeriodValue
Q3 2025147.50%
Q2 20250.00%
Q1 20250.00%
Q4 20240.00%
Q3 20240.00%
Q2 20240.00%
Q1 20240.00%
Q4 20230.00%
Q3 20230.00%
Q2 20230.00%
Q1 20230.00%
Q4 2022100.00%
Q3 2022-5.04%
Q2 2022-9.09%
Q1 20220.00%
Q4 2021100.00%
Q3 2021-456.00%
Q2 2021-11.11%
Q1 202125.62%
Q4 20200.00%
Q3 2020100.00%
Q2 20200.00%
Q1 20200.00%